J9394
HCPCSInj, fulvestrant (fresenius)
Official HCPCS Level II long descriptor
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
HCPCS Level II code J9394 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, fulvestrant (fresenius)
Added to HCPCS: 2023-01-01
Nearby codes in J9
- J9361Inj, efbemalenograstim alfa-
- J9370Vincristine sulfate 1 mg inj
- J9376Inj pozelimab-bbfg, 1 mg
- J9380Inj teclistamab cqyv 0.5 mg
- J9381Inj teplizumab mzwv 5 mcg
- J9382Inj zenocutuzumab-zbco 1 mg
- J9390Vinorelbine tartrate inj
- J9393Inj, fulvestrant (teva)
- J9395Injection, fulvestrant
- J9400Inj, ziv-aflibercept, 1mg
- J9600Porfimer sodium injection
- J9601Inj linvoseltamab-gcpt 1 mg
- J9999Chemotherapy drug
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.